Clinical Trials Directory

Trials / Completed

CompletedNCT01840397

Neuromarker S-100B as Diagnostic Tool

Elevated Levels of S-100B and Neuron-specific Enolase (NSE) in Spine Surgery: A Comparison of Serum Levels With Surgery for Long-bone Fractures

Status
Completed
Phase
Study type
Observational
Enrollment
30 (estimated)
Sponsor
Medical University of Vienna · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The hypothesis of this study is to find evidence if there is an influence of spine surgery on the serum levels of two proteins secreted from neuronal cells.

Detailed description

The question, if there is an effect on the cerebrospinal system during spine surgery, which can be traced by monitoring serum levels of neuromarkers is not yet answered. This study has its background from other studies on patients with traumatic brain injury (TBI), in whom elevated serum levels of the two neuromarkers S-100B and NSE are associated with injury severity, neuronal damage, brain, tissue damage, and outcome. Patients undergoing spine surgery with or without pre-existing traumatic neurologic symptoms are planned to be the study cohort. Pre- and postoperatively the serum levels of S-100B and NSE are obtained and are statistically compared with patients undergoing other types of bone-related surgery.

Conditions

Timeline

Start date
2013-03-01
Primary completion
2013-11-01
Completion
2013-11-01
First posted
2013-04-25
Last updated
2013-11-21

Locations

1 site across 1 country: Austria

Source: ClinicalTrials.gov record NCT01840397. Inclusion in this directory is not an endorsement.